Loading provider…
Loading provider…
Internal Medicine Physician in Philadelphia, PA
NPI: 1316979610Primary Practice Location
HOSPITAL OF UNIV OF PENNSYLVANIA
3400 Spruce St, Philadelphia, PA
Primary Employer
Perelman Center for Advanced Medicine
pennmedicine.org
HQ Phone
Get MD Daniel's Phone Numberphone_androidMobile
Get MD Daniel's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardPA State Medical License
PA State Medical License
1993 - 2026
MD State Medical License
1988 - 1995

American Board of Internal Medicine
Internal Medicine
National Heart Lung and Blood Institute (NHLBI)
Post-Doctoral Fellowship • 1998 - 2003
1998 - 2003
Yale-New Haven Medical Center
Residency • Internal Medicine
1984 - 1987
MCP-Hahnemann College of Medicine
Medical School
Until 1984
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 12 | 12 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 12 | 12 |
| 3 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 11 | 11 |
Authors: John Millar
Journal: J Gene Med
Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell?
Authors: Rader, Daniel J, Puré, Ellen
Journal: Cell Metab
Lead Sponsor: Regeneron Pharmaceuticals
Collaborators: Sanofi
Intervention / Treatment: DRUG: Statin, DRUG: Alirocumab, DRUG: Placebo (for alirocumab)
Lead Sponsor: Sanofi
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Lipid Modifying Therapy (LMT), DRUG: Alirocumab, DRUG: Placebo (for alirocumab)
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: evinacumab